Soroka Medical Center
Beersheba, Israel
NCT Number: NCT05502926
Patients undergoing surgery inside their abdomen, with no serious heart or lung diseases, will have a lung ultrasound exam before and after surgery. The patient respiratory status in the post-operative unit and the surgical ward will be monitored for complications after surgery
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Beersheba, Israel
The study will be performed in the Soroka hospital operating room and recovery unit.
On admission to pre-surgery, patients will be investigates for inclusion and exclusion criteria. Those that are eligible for the study will be asked to give formal consent to participate in the study. After consent the examiner will review the patient's past medical history and surgery plan, and will preform the pre-operative LUS exam.
After surgery, the examiner will review the electronic anesthesia record and will preform the post-operative LUS exam within 30 minutes of arrival to the recovery unit or 30 minutes from extubation (in patients that were admitted to the recovery unit still under mechanical ventilation). Upon discharge from the recovery unit the examiner will review the recovery unit electronic record.
After discharge, the examiner will review the patient post-operative surgical ward electronic record.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The population study will include patients 18 years and older, with ASA class I, II or III, presenting for elective intra-abdominal surgery under general anesthesia and are not planned for long-term post-surgical mechanical ventilation.
Exclusion criteria
Patient will be excluded from the study if they have pre-existing moderate or severe heart or lung disease: a history of ischemic heart disease, moderate or severe systolic or diastolic heart failure, moderate or severe pulmonary hypertension, moderate or severe obstructive or interstitial lung disease. Patients will also be excluded if they had a severe intra-operative pulmonary complication (laryngospasm, bronchospasm, anaphylaxis, emergency surgical airway). Patients who require un-planned long term mechanical ventilation or those who died during surgery will also be excluded.
peroperative and postoperative 12 point trans-thoracic lung ultrasound
Time frame: 48 hours
any kind of oxygen therapy (face mask, nasal cannula, CPAP/BIPAP) more then 12 hours after and of surgery, or desaturation <90%
Time frame: during hospital stay
unplanned postoperative admission to icu or re-intubation
Time frame: 48 hours
clinical or radiographic diagnosis of pneumonia
Time frame: 48 hours
postoperative death of any cause
Time frame: during hospital stay
total length of stay at the post operative care unit
Time frame: during hospital stay
total time with oxygen treatment (nasal cannula, face mask) in the post operative care unit
Time frame: during hospital stay
oxygen treatment (nasal cannula, face mask) on discharge from the post operative care unit
Moshe Rucham MD
Other
Perioperative Lung Ultrasound Score (LUS) for Prediction of Postoperative Pulmonary Complications (PPC)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04828408
Anesthesia, Bariatric Surgery
Bursa, Yıldırım, Turkey (Türkiye)
View Trial DetailsNCT06711601
Intercristal Line, Posterior Superior Iliac Spine
Guangzhou, Guangdong, China
View Trial DetailsNCT07041567
Atelectasis, Bariatric Surgery
Istanbul, Goztepe, Turkey (Türkiye)
View Trial DetailsNCT05294757
Atrophy, Behavior
Albacete, Castille-La Mancha, Spain
View Trial Details